Tetrabenazine - CAS 58-46-8
Catalog number: 58-46-8
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C19H27NO3
Molecular Weight:
317.42
COA:
Inquire
Targets:
Others
Description:
Tetrabenazine is a VMAT-inhibitor used for treatment of hyperkinetic movement disorder. It is a monoamine-depleting and a dopamine-receptor-blocking drug and is an effective and safe drug for the treatment of a variety of hyperkinetic movement disorders.
Purity:
>98%
Synonyms:
Rubigen; Xenazine;
Ro 1-9569
MSDS:
Inquire
InChIKey:
MKJIEFSOBYUXJB-UHFFFAOYSA-N
InChI:
InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3
Canonical SMILES:
CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC
1.Tetrabenazine-induced oculogyric crisis - a rare complication in the treatment of Gilles de la Tourette syndrome.
Janik P1, Figura M2. Neuropsychiatr Dis Treat. 2016 Feb 25;12:497-9. doi: 10.2147/NDT.S98694. eCollection 2016.
Tetrabenazine is used in the treatment of chorea, tardive dyskinesia, tics, and dystonia. It rarely causes acute eyeball dystonia and the description of this complication in Gilles de la Tourette syndrome is limited. We provide a description of an acute oculogyric crisis caused by tetrabenazine in a patient with severe tics. The patient had never developed acute dystonic reactions, although he was previously exposed to numerous dopamine receptor-blocking agents. After 8 days of therapy with tetrabenazine at a dose of 62.5 mg daily, the patient developed involuntary movement of the eyeballs. Withdrawal of tetrabenazine caused resolution of all symptoms after a week. The purpose of this description is to draw attention to the potential of tetrabenazine to induce acute oculogyric crisis as well as the difficulty of differentiating drug-induced dystonia from dystonic tics in patients with Gilles de la Tourette syndrome.
2.Synthesis of (±)-Tetrabenazine by Visible Light Photoredox Catalysis.
Orgren LR1, Maverick EE1, Marvin CC1. J Org Chem. 2015 Dec 18;80(24):12635-40. doi: 10.1021/acs.joc.5b02199. Epub 2015 Nov 13.
(±)-Tetrabenazine was synthesized in six steps from commercially available compounds. The key cyclization substrate was assembled rapidly via Baylis-Hillman and aza-Michael reactions. Annulation of the final ring was achieved through visible light photocatalysis, wherein carbon-carbon bond formation was driven by the oxidation of a tertiary amine. Solvent played a critical role in the photoredox cyclization outcome, whereas methanol led to a mixed ketal, acetonitrile/water (10:1) gave direct cyclization to (±)-tetrabenazine and occurred more rapidly.
3.The MAO-B inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the VMAT-2 inhibitor tetrabenazine.
Podurgiel SJ1, Yohn SE1, Dortche K1, Correa M2, Salamone JD3. Behav Brain Res. 2016 Feb 1;298(Pt B):188-91. doi: 10.1016/j.bbr.2015.11.008. Epub 2015 Nov 15.
Tetrabenazine (TBZ) is prescribed for the treatment of chorea associated with Huntington's disease. Via inhibition of the vesicular monoamine transporter (VMAT-2), TBZ blocks dopamine (DA) storage and depletes striatal DA; this drug also has been shown to induce Parkinsonian motor side effects in patients. Recently, TBZ was shown to induce tremulous jaw movements (TJMs) in rats and mice. TJMs are an oral tremor that has many of the characteristics of Parkinsonian tremor in humans. The present study focused upon the ability of the well-established antiparkinsonian agent deprenyl to attenuate the behavioral and neurochemical effects of 2.0mg/kg TBZ. Deprenyl is a selective and irreversible inhibitor of monoamine oxidase-B, and administration of deprenyl produced a dose-related suppression of TBZ-induced TJMs. A second experiment employed in vivo microdialysis to examine extracellular DA levels in the ventrolateral striatum, the neostriatal region most closely associated with the production of TJMs, after administration of TBZ and deprenyl.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 119757-73-2 Tautomycetin

Tautomycetin
(CAS: 119757-73-2)

Tautomycetin is a selective inhibitor of protein phosphatase (PP)1 (IC50 = 1.6 and 62 nM for PP1 and PP2, respectively) used as an immunosuppressive agent. Taut...

CAS 84605-18-5 Cycloastragenol

Cycloastragenol
(CAS: 84605-18-5)

Cycloastragenol is a natural tetracyclic triterpenoid. It is an aglycone derivative of astragaloside IV found in the root of Korean Astragalus membranaceus. It ...

CAS 478-01-3 Nobiletin

Nobiletin
(CAS: 478-01-3)

Nobiletin, a citrus flavonoid isolated from citrus peels like in tangerine, which has anti-inflammatory and anti-tumor activities.

FR-182024
(CAS: 179034-83-4)

FR-182024, an azabicyclo derivative, has been found to have potential activity as an anti-Helicobacter pylori agent and was once stuied against helicobacter inf...

CAS 56180-94-0 Acarbose

Acarbose
(CAS: 56180-94-0)

Acarbose is an inhibitor of intestinal alpha-glucosidase, used to treat type 2 diabetes mellitus.

CAS 69884-00-0 Pseudoginsenoside-F11

Pseudoginsenoside-F11
(CAS: 69884-00-0)

Pseudoginsenoside- F11 is extracted from the roots of Panax ginseng C. A. Mey, has been demonstrated to antagonize the learning and memory deficits induced by s...

CAS 58-96-8 Uridine

Uridine
(CAS: 58-96-8)

Uridine is a nucleoside, contains a uracil attached to a ribose ring via a β-N1-glycosidic bond.

SV40 large T antigen NLS

SV40 large T antigen NLS, a hexamer protein generated from Large T antigen residue 47 to 55, enables protein import into cell nucleus.

KHK-IN-1 hydrochloride
(CAS: 1303470-48-5)

The hydrochloride salt form of KHK-IN-1 which is a ketohexokinase inhibitor that could have probable effect against diabetes and obesity by acting on Asp-27B in...

CAS 162203-65-8 JTP-4819

JTP-4819
(CAS: 162203-65-8)

JTP-4819, a pyrrolidine derivative, has been found to be a PEP inhibitor that was once studied in cognition disorders and had been already been discontinued.

CAS 471-95-4 Bufotalin

Bufotalin
(CAS: 471-95-4)

Bufotalin is a cardiotoxic bufanolide steroid, cardiac glycoside analogue, secreted by a number of toad species. It is a novel anti-osteoblastoma agent.

CAS 102791-47-9 Nanterinone

Nanterinone
(CAS: 102791-47-9)

Nanterinone is a novel positive inotropic and balanced-type vasodilating drug partially based on phosphodiesterase III inhibition. It exhibits acute hemodynamic...

CAS 305-03-3 Chloroambucil

Chloroambucil
(CAS: 305-03-3)

Chlorambucil (marketed as Leukeran by GlaxoSmithKline) is a chemotherapy drug that has been mainly used in the treatment of chronic lymphocytic leukemia. It is ...

CAS 50-56-6 Oxytocin

Oxytocin
(CAS: 50-56-6)

Oxytocin is a mammalian neurohypophysial hormone. It plays an important role in the neuroanatomy of intimacy, specifically in sexual reproduction of both sexes,...

ENT 25642
(CAS: 1713-54-8)

ENT 25642, a sulfamide derivative, could have potential activities in sorts of biological studies.

CP-69799
(CAS: 105116-61-8)

CP-69799 is an inhibitor of aspartate proteinases.

CAS 1429218-03-0 HL 010183

HL 010183
(CAS: 1429218-03-0)

HL 010183 is a metformin derivative exhibiting potent antitumor effect. It inhibits proliferation and invasion of Hs578T triple-negative (TN) breast cancer cell...

CAS 13860-66-7 N3PT

N3PT
(CAS: 13860-66-7)

N3PT inhibits transketolase activity in a cell based assay. Competitive inhibition of TK by N3PT in cells treated with increasing doses of thiamine, expressed a...

CAS 611-75-6 Bromhexine Hydrochloride

Bromhexine Hydrochloride
(CAS: 611-75-6)

Bromhexine is a mucolytic (expectorant) agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. In addition, bromhexine ...

GSK-1268992
(CAS: 1414375-49-7)

GSK-1268992 is one of a metabolite of Pazopanib which is a selective multi-targeted receptor tyrosine kinase inhibitor that blocks tumour growth and inhibits an...

Chemical Structure

CAS 58-46-8 Tetrabenazine

Quick Inquiry

Verification code

Featured Items